or Try an Advanced Search...

    Technical Analysis for SERA - Sera Prognostics, Inc

    Grade Last Price % Change Price Change
    F 6.04 2.03% 0.12
    SERA closed up 2.03 percent on Monday, July 1, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SERA trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Pocket Pivot Bullish Swing Setup 2.03%
    Volume Surge Other 2.03%
    Wide Bands Range Expansion 2.03%
    Oversold Stochastic Weakness 2.03%
    Slingshot Bearish Bearish Swing Setup 5.59%
    Lower Bollinger Band Walk Weakness 5.59%
    Wide Bands Range Expansion 5.59%
    Older End-of-Day Signals for SERA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    200 DMA Resistance about 9 hours ago
    Up 5% about 9 hours ago
    Up 3% about 9 hours ago
    Up 2% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SERA Chart by TradingView
    Basic chart:

    Profile

    Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Fertility Obstetrics Childbirth Women's Health Human Pregnancy Midwifery Pregnancy Preterm Birth

    Is SERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Sera Prognostics joins Russell 2000, Russell 3000 indexes
    Jul 1 SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION
    Jun 20 Sera Prognostics, Inc. (NASDAQ:SERA) most popular amongst individual investors who own 31% of the shares, institutions hold 29%
    May 28 SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
    May 10 Sera Prognostics Inc Reports Q1 2024 Results: A Closer Look at Financials and Strategic Moves
    May 10 Sera Prognostics First Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.34 loss in 1Q 2023)
    May 9 Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript
    May 9 Sera Prognostics, Inc. (SERA) Q1 2024 Earnings Call Transcript
    May 8 Sera Prognostics GAAP EPS of -$0.25 beats by $0.02
    May 8 SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
    See more SERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.355
    52 Week Low 1.52
    Average Volume 218,777
    200-Day Moving Average 6.29
    50-Day Moving Average 8.66
    20-Day Moving Average 7.41
    10-Day Moving Average 6.41
    Average True Range 0.62
    RSI (14) 29.58
    ADX 35.02
    +DI 13.26
    -DI 36.18
    Chandelier Exit (Long, 3 ATRs) 8.05
    Chandelier Exit (Short, 3 ATRs) 6.84
    Upper Bollinger Bands 9.68
    Lower Bollinger Band 5.14
    Percent B (%b) 0.2
    BandWidth 61.39
    MACD Line -0.83
    MACD Signal Line -0.68
    MACD Histogram -0.1433
    Fundamentals Value
    Market Cap 183.43 Million
    Num Shares 30.4 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -4.91
    Price-to-Sales 806.20
    Price-to-Book 3.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.56
    Resistance 3 (R3) 6.59 6.44 6.47
    Resistance 2 (R2) 6.44 6.31 6.43 6.44
    Resistance 1 (R1) 6.24 6.23 6.34 6.21 6.41
    Pivot Point 6.10 6.10 6.15 6.08 6.10
    Support 1 (S1) 5.90 5.96 6.00 5.87 5.67
    Support 2 (S2) 5.75 5.88 5.74 5.64
    Support 3 (S3) 5.55 5.75 5.61
    Support 4 (S4) 5.52